Now that device companies have closed the book on 2016 and are offering projections for 2017, Medtech Insight is reviewing the 2016 full-year reports from some of the big newsmakers. Here are some of the companies that made progress in 2016, some that struggled, and a few that are worth keeping an eye on in 2017.
Boston Scientific Corp. (BSX)'s growth continues to accelerate, with strong results across the business. On Feb. 2, the company reported fourth-quarter revenue of $2.191bn, an 11% increase over the same...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?